Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
- To assess the efficacy of MEDI4736 + tremelimumab combination therapy versus SoC in terms of OS
Critère d'inclusion
- Recurrent or metastatic PD-L1-positive or negative squamous cell carcinoma of the head and neck (SCCHN)